Your session is about to expire
← Back to Search
Twitter for African American caregivers for Stress (Tweet-S2 Trial)
N/A
Waitlist Available
Led By Sunmoo Yoon, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
a dementia caregiver with any duration, able to speak English or Spanish/bilingual
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Tweet-S2 Trial Summary
This trial aims to study how social media affects the discussion of dementia and caregivers' networking styles among African Americans and Hispanics.
Who is the study for?
This trial is for Black or Hispanic dementia caregivers living in the U.S., who are 18 or older, can speak English or Spanish, and use a smartphone. They must agree to Twitter's terms of service and privacy policies, and join one of two Twitter networks designed for their demographic.Check my eligibility
What is being tested?
The study tests if using tailored Twitter support networks can affect discussion topics, sentiment, and networking (like number of followers) among Black (@dcnaab) and Hispanic (@dcnh) dementia caregivers.See study design
What are the potential side effects?
Since this trial involves social media use rather than medical interventions, traditional side effects aren't expected. However, participants may experience emotional impacts from online interactions.
Tweet-S2 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a caregiver for someone with dementia and I speak English, Spanish, or both.
Select...
I am 18 years old or older.
Tweet-S2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Emotional valence score
Fraction of isolates
Secondary outcome measures
Number of auto-detected small groups
Number of individual posting activities with balanced communication type
Tweet-S2 Trial Design
2Treatment groups
Experimental Treatment
Group I: Hispanic dementia caregiversExperimental Treatment1 Intervention
De-identified followers of our Hispanic dementia caregiver Twitter network will receive messages from the network (Twitter for Hispanic caregivers' intervention).
Group II: African American dementia caregiversExperimental Treatment1 Intervention
De-identified followers of our African American dementia caregiver Twitter network will receive messages from the network (Twitter for African American caregivers' intervention).
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,459,865 Total Patients Enrolled
Department of Health and Human ServicesFED
226 Previous Clinical Trials
927,983 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,098 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a caregiver for someone with dementia and I speak English, Spanish, or both.This does not apply to me as I am not a child.You cannot participate if you have a Twitter account that is not anonymous.I am 18 years old or older.You have a smartphone or a cell phone with text messaging capabilities.You are not taking care of a family member with dementia.
Research Study Groups:
This trial has the following groups:- Group 1: Hispanic dementia caregivers
- Group 2: African American dementia caregivers
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still space available to volunteer for this medical experiment?
"This research study is currently seeking participants; the listing was initially published on December 1st 2022 and revised on September 23rd."
Answered by AI
What is the scope of people participating in this experiment?
"That is accurate. Clinicaltrials.gov reveals that the medical trial, which was initially advertised on 12th January 2022, is actively looking for participants. The search will involve approximately 800 people from a single research facility."
Answered by AI
Share this study with friends
Copy Link
Messenger